Skip to main content
JAMA Network logoLink to JAMA Network
. 2021 Oct 26;326(16):1637. doi: 10.1001/jama.2021.17311

Unclear Diagnostic Testing Standard

PMCID: PMC8548940  PMID: 34698803

In the US Preventive Services Task Force Recommendation Statement titled “Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement,” published in the August 24, 2021, issue of JAMA,1 a diagnostic testing standard was unclear. In the “Practice Considerations” section, the last sentence of the “Screening Tests” subsection should have read “The diagnosis of type 2 diabetes should be confirmed with repeat testing.” This article was corrected online.

Reference

  • 1.Davidson KW, Barry MJ, Mangione CM, et al. ; US Preventive Services Task Force . Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(8):736-743. doi: 10.1001/jama.2021.12531 [DOI] [PubMed] [Google Scholar]

Articles from JAMA are provided here courtesy of American Medical Association

RESOURCES